Supporting the Biggest Brands in Cell and Gene Therapy

Services Available

Reach Your Audience through Content and Get Noticed By Brand New Prospects
Meet the Content Team

Georgi is the Editor for Phacilitate and is therefore responsible for the content published …

Editorial Assistant

Anna is the Editorial Assistant at Phacilitate, responsible for reporting on current news within …

Marketing Executive

Ashley is the new Marketing Executive at Phacilitate. He is responsible for ensuring the web…

Vice President, Commercial Operations

David heads up the Phacilitate commercial team, overseeing the future direction, commercial …

Commercial Director

As part of the sales team, Will helps the Phacilitate network to connect with the right comm…

Commercial Director

Peter has been a Phacilitate sales superstar for 6 years now. Originally hailing from the Emerald Isle, Peter is an expert i…

Sample Content


Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

The late-stage cell and gene therapy company Castle Creek Biosciences has announced a $112.8 million preferred stock financing to advance the development and commercialization of gene therapies using their lentiviral platforms.
26th May 2022

How Collaboration and Simplification is Key to Solving Industry-Wide Efficacy and Supply Chain Challenges

John Kempshead, COO/Senior Director of Clinical Scientific Affairs at Biomagnetic Solutions, discusses the applications of simplification and collaboration in order to tackle supply chain limitations.
26th May 2022

Key Takeaways from ASGCT 2022

Ryan Leahy summarizes his key takeaways from his first Annual Meeting of the American Society for Gene and Cell Therapy.
25th May 2022
Washington, DC